Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, has appointed Dominik Kugelstadt head of clinical and commercial manufacturing of the Laupheim site, and will serve as a member of the Laupheim leadership team. Kugelstadt is responsible for all areas of production and reports to Laupheim’s site head. With his extensive experience in the manufacture of complex biologics and comprehensive knowledge of production management, Kugelstadt will play a leading role in ensuring the qualit...